Literature DB >> 10550823

Principles of chemoradiation: theoretical and practical considerations.

L L Herscher1, J A Cook, R Pacelli, H I Pass, A Russo, J B Mitchell.   

Abstract

Chemotherapy agents known to enhance the effects of radiation in preclinical studies have been used concurrently with radiotherapy in numerous clinical trials with the prospect of further enhancing radiation-induced local tumor control. While some success in several tumor histologies has been achieved using this approach, a major concern has been enhancement in normal tissue toxicity. This brief review addresses both theoretical and practical issues with respect to chemoradiation clinical trials. Recommendations for clinical trials are provided that, if implemented, can increase our understanding of basic mechanisms (in patients) and provide a more rational approach for future trials.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550823

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  9 in total

Review 1.  Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer.

Authors:  Robert MacRae; Hak Choy
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.075

2.  DNA topoisomerase I drugs and radiotherapy for lung cancer.

Authors:  Allan Y Chen; Patricia M T Chen; Yi-Jen Chen
Journal:  J Thorac Dis       Date:  2012-08       Impact factor: 2.895

3.  Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses.

Authors:  Guozheng Guo; Yan Yan-Sanders; Beverly D Lyn-Cook; Tieli Wang; Daniel Tamae; Julie Ogi; Alexander Khaletskiy; Zhongkui Li; Christine Weydert; Jeffrey A Longmate; Ting-Ting Huang; Douglas R Spitz; Larry W Oberley; Jian Jian Li
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 4.  ATM-NF-kappaB connection as a target for tumor radiosensitization.

Authors:  Kazi Mokim Ahmed; Jian Jian Li
Journal:  Curr Cancer Drug Targets       Date:  2007-06       Impact factor: 3.428

Review 5.  NF-kappa B-mediated adaptive resistance to ionizing radiation.

Authors:  Kazi Mokim Ahmed; Jian Jian Li
Journal:  Free Radic Biol Med       Date:  2007-10-10       Impact factor: 7.376

6.  Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.

Authors:  James Welsh; Stephen H Settle; Arya Amini; Lianchun Xiao; Akihiro Suzuki; Yuki Hayashi; Wayne Hofstetter; Ritsuko Komaki; Zhongxing Liao; Jaffer A Ajani
Journal:  Cancer       Date:  2011-10-05       Impact factor: 6.860

7.  Irreversible EGFR inhibitor EKB-569 targets low-LET γ-radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma.

Authors:  Natarajan Aravindan; Charles R Thomas; Sheeja Aravindan; Aswathi S Mohan; Jamunarani Veeraraghavan; Mohan Natarajan
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

8.  Peptide Mediated In Vivo Tumor Targeting of Nanoparticles through Optimization in Single and Multilayer In Vitro Cell Models.

Authors:  Celina Yang; Kyle Bromma; Devika Chithrani
Journal:  Cancers (Basel)       Date:  2018-03-20       Impact factor: 6.639

Review 9.  Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy.

Authors:  Abdulaziz Alhussan; Ece Pinar Demirci Bozdoğan; Devika B Chithrani
Journal:  Pharmaceutics       Date:  2021-03-25       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.